[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

07/16/2025 - 04:30 PM

Filing content is currently unavailable.

Source:

Kiniksa Pharmaceuticals International, plc

NASDAQ:KNSA

KNSA Rankings

#1901 Ranked by Market Cap

N/A Ranked by Dividends

KNSA Latest News

Aug 28, 2025

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Jul 29, 2025

Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution

Jul 24, 2025

Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July聽29, 2025

Jun 5, 2025

Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis

May 29, 2025

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

KNSA Latest SEC Filings

Aug 20, 2025

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

Aug 18, 2025

[144] Kiniksa Pharmaceuticals International, plc SEC Filing

Aug 14, 2025

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

Aug 14, 2025

[144] Kiniksa Pharmaceuticals International, plc SEC Filing

Aug 13, 2025

[144] Kiniksa Pharmaceuticals International, plc SEC Filing

KNSA Stock Data

Market Cap 2.50B

Float 41.84M

Insiders Ownership 3.68%

Institutions Ownership 93.03%

Short Percent 3.28%

Industry Drug Manufacturers - Specialty & Generic

Sector Pharmaceutical Preparations

Website

Country United Kingdom

City LONDON

AG真人官方

Trending News